Abstract
Fertility-sparing surgery in early-stage epithelial ovarian cancer is a feasible option for patients of childbearing age wishing for a future pregnancy. The therapeutic option needs to be managed by an expert Gynecologic Oncologist within a multispeciality oncologic team. This chapter reviews the clinical condition which may influence the final decision, in particular: stage of disease, grade of differentiation, and histologic subtype. Oncological outcomes and fertility outcomes are reported on the basis of the currently available literature.
Keywords: Chemotherapy, Early stage, Fertility, Histologic subtype, Ovarian cancer, Offspring, Pregnancy, Surgery.
Related Books
Advances in Cancer Nanotheranostics for Experimental and Personalized Medicine
Cancer Metastasis and Cancer Stem Cell/Niche
Cancer Preventive and Therapeutic Compounds: Gift From Mother Nature
Controversies in Neuro-Oncology
Current Advances in Breast Cancer Research: A Molecular Approach
Cutting Edge Therapies for Cancer in the 21st Century
Frontiers in Cancer Immunology
Frontiers in Cancer Immunology
Frontiers in Clinical Drug Research - Anti-Cancer Agents
Frontiers in Clinical Drug Research - Anti-Cancer Agents